Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
about
Worldwide Prevalence and Trends in Unintentional Drug Overdose: A Systematic Review of the LiteratureReducing Fatal Opioid Overdose: Prevention, Treatment and Harm Reduction StrategiesAre take-home naloxone programmes effective? Systematic review utilizing application of the Bradford Hill criteriaOpioid overdose rates and implementation of overdose education and nasal naloxone distribution in Massachusetts: interrupted time series analysisEndogenous opiates and behavior: 2006Shooting gallery attendance among IDUs in Tijuana and Ciudad Juarez, Mexico: correlates, prevention opportunities, and the role of the environment.Preventing death among the recently incarcerated: an argument for naloxone prescription before release.Overdose experiences among injection drug users in Bangkok, ThailandA quantitative and qualitative evaluation of the British Columbia Take Home Naloxone program.Overdose prevention and naloxone prescription for opioid users in San FranciscoPreventing opiate overdose deaths: examining objections to take-home naloxone.Coverage of overdose prevention programs for opiate users and injectors: a cross-sectional studyRisk factors for nonfatal overdose at Seattle-area syringe exchanges.Evaluation of a naloxone distribution and administration program in New York City.Evaluation of an overdose prevention and response training programme for injection drug users in the Skid Row area of Los Angeles, CA.Epidemiologic trends and geographic patterns of fatal opioid intoxications in Connecticut, USA: 1997-2007.Overdose rescues by trained and untrained participants and change in opioid use among substance-using participants in overdose education and naloxone distribution programs: a retrospective cohort study.Distinguishing signs of opioid overdose and indication for naloxone: an evaluation of six overdose training and naloxone distribution programs in the United States.Characteristics of an overdose prevention, response, and naloxone distribution program in Pittsburgh and Allegheny County, Pennsylvania.Overdose prevention for injection drug users: lessons learned from naloxone training and distribution programs in New York City.Messaging to Increase Public Support for Naloxone Distribution Policies in the United States: Results from a Randomized Survey ExperimentMortality among young injection drug users in San Francisco: a 10-year follow-up of the UFO study.A Review of Opioid Overdose Prevention and Naloxone Prescribing: Implications for Translating Community Programming Into Clinical Practice.Attitudes and knowledge about naloxone and overdose prevention among detained drug users in Ningbo, China.Development and process evaluation of an educational intervention for overdose prevention and naloxone distribution by general practice traineesPredictors of participant engagement and naloxone utilization in a community-based naloxone distribution program.Association between non-fatal opioid overdose and encounters with healthcare and criminal justice systems: Identifying opportunities for interventionHIV infection and risk of overdose: a systematic review and meta-analysisOrienting patients to greater opioid safety: models of community pharmacy-based naloxone.Intravenous use of illicit buprenorphine/naloxone to reverse an acute heroin overdose.Distribution of naloxone for overdose prevention to chronic pain patients.More than just someone to inject drugs with: Injecting within primary injection partnerships.Observed patterns of illicit opiate overdose deaths in Chicago, 1999-2003Injection drug users trained by overdose prevention programs: responses to witnessed overdoses.A qualitative study of overdose responses among Chicago IDUsStakeholder perceptions and operational barriers in the training and distribution of take-home naloxone within prisons in England.Attitudes of Australian heroin users to peer distribution of naloxone for heroin overdose: perspectives on intranasal administrationA response to the opioid overdose epidemic: naloxone nasal sprayQualitative assessment of take-home naloxone program participant and law enforcement interactions in British Columbia.Fentanyl epidemic in Chicago, Illinois and surrounding Cook County.
P2860
Q26785445-1D4C60E4-9EEB-43FE-9E18-4C1BD446F535Q26785478-CD3D7049-9F5C-4B4D-A71E-7E3B41259B09Q28075931-426E9F99-E0B3-4062-B987-7E68370085C2Q28397248-F837B148-DB15-418D-A4A0-2BDE9490274CQ28752585-E0535B35-D70B-4CE4-BCD2-D720CDD56B9BQ33325936-E54AB8FE-0646-4809-A339-8E000B684A9CQ33775772-15CA83EB-8248-4B13-A58E-A6C44EF22D85Q33892468-895BBDE0-0121-4F78-8641-B6A9F1EA4378Q34280151-91104AA5-26B4-43F3-B3C0-584495461EF4Q34420178-EEAEC50C-0AD7-469E-BA72-D2CB0ACD985EQ34434452-34019DA9-38BF-4298-ADF4-7E1BADCA654AQ34587153-838760D7-0CB6-4FBE-BE51-9F01B0CF710AQ34588009-28197931-7475-4855-99D6-58BBDCD0B71FQ34788017-BB9B6CC8-BB98-463B-AD7B-17CB1B6F4194Q34923675-440EB449-3A17-487A-BD59-2DA6F1FF6EEBQ34984833-C154617B-9C99-4ACC-935B-414FF383F03FQ35135608-5A2F7CE6-C47C-4520-9388-1E36C88944F0Q35186225-811D88A3-2276-4BBF-AAC4-2659B95092DCQ35597413-4E4682D3-0EBF-45A9-A3A5-9747D9362AA7Q35633605-BDD18B22-0A53-42B0-AAE1-B1B84A6249FEQ35680274-B68D2C40-F45C-4C87-B0AD-977E7DC9F082Q35734357-3A8A311E-D8E9-40A4-84B4-81A3DD2FCB16Q35751870-E5CAE5E2-A6D8-4223-8066-63FC75A7A607Q35808935-92CCC5AB-740D-475A-9749-4F7863B861A6Q35847707-3F86213D-13EB-426B-8552-E66E918F05B3Q35855231-72978F39-9B13-4856-8334-DAA7CDDE559AQ35882669-7D6832EF-2323-48AE-BB97-0BBE31CD0C69Q35898498-E8366E11-B944-4193-BCB6-09F0AC853778Q35923351-B567F6AC-3249-4B9F-9D3E-20444DFE8403Q35932315-56925FC2-DC1C-4A32-9740-DDA08986DB51Q36117657-B103DB50-BE19-4347-9ED9-15AE663AE703Q36248999-1D387939-7474-465B-A937-832E2CC55274Q36440643-6F4932B5-57E8-43C1-A0C8-D866D6B6B2ABQ36451555-B8A5C432-C2A0-4505-BD43-9401C185BF47Q36464659-AD444D23-6E17-452A-A74B-1064538CDF47Q36537375-3E6871B8-B571-4CB0-A389-F29552B84379Q36579537-D7DA34C7-A3D7-4395-B139-7D4D057D39FBQ36890018-7AF9A9EB-7175-4E11-8201-CAEB14A02F45Q36923289-11AB5716-4154-4D36-BEEE-3BFA5A229D13Q37201531-8F6DCD32-CC0D-496E-8E05-D31FAE03A6DD
P2860
Prescribing naloxone to actively injecting heroin users: a program to reduce heroin overdose deaths.
description
2006 nî lūn-bûn
@nan
2006 թուականի Յունուարին հրատարակուած գիտական յօդուած
@hyw
2006 թվականի հունվարին հրատարակված գիտական հոդված
@hy
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
name
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@ast
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@en
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@nl
type
label
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@ast
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@en
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@nl
prefLabel
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@ast
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@en
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@nl
P2093
P2860
P356
P1476
Prescribing naloxone to active ...... reduce heroin overdose deaths.
@en
P2093
Karen Stanczykiewicz
Sarz Maxwell
Suzanne Carlberg-Racich
P2860
P356
10.1300/J069V25N03_11
P50
P577
2006-01-01T00:00:00Z